SHOW DIRECTORY
Invest Like the Best
Deep conversations with investors, founders, and operators about business quality, capital allocation, strategy, and enduring competitive advantage.
BIDCLUB DESCRIPTION
The Flaw Behind Everything Wrong With US Healthcare
Patrick O'ShaughnessyZach Reitano
Healthcare spending can grow if it buys more healthy years, but Reitano argues America’s core flaw is that “the patient is not the client.”Ro’s cash-pay GLP-1 model can lower prices and increase drugmaker profits through volume, while investment in records, labs, pharmacies, and clinical networks helped it scale demand.After a reset, Ro grew annual revenue from approximately $250 million to more than $3 billion over four years; broader GLP-1 adoption still depends on access, tolerability, and continued innovation.
What Happens When the AI Boom Slows Down
Patrick O'ShaughnessyMartin Casado
Frontier models captured 80%+ of dollar-weighted demand over three years, yet Casado estimates an individual model’s commercial lifespan at just three to six months.Startups may still pay 10 times more for the smartest model, sustaining pricing power even as coding workflows saturate.If demand saturates, value could shift to open source, a transition Casado says “nobody knows” how it would unfold.
Christina Cacioppo - Building an Enduring Software Company in the Age of AI - [Invest Like the Best, EP.496]
Patrick O'ShaughnessyChristina Cacioppo
Christina Cacioppo says Vanta’s 400-integration “trust graph” helps the roughly eight-year-old company build software and agents faster.About 25% of customers use agent flows; she expects raising that share to 75% to improve retention and customer experience.Vanta absorbs token costs rather than passing them through, since markups invite Claude comparisons, leaving commercialization and margin recovery unresolved.
Andrew Huberman - The Frontier of Neurotechnology - [Invest Like the Best, EP.494]
Patrick O'ShaughnessyAndrew Huberman
Sleep is the near-term neurotechnology wedge because users already accept physiological measurement, while an eye mask reportedly measures REM, induces sleep-promoting eye movements, and amplifies REM, with related technology expected in roughly seven to 12 months.Huberman predicts Meta, OpenAI, Anthropic, and Elon’s Neuralink effort will converge on neural read/write biotech, but missing models of memory and thought, plus a possible 2027-28 downturn in optimization content, remain key risks.
Inside the Personal AI Assistant Growing 10% a Day | Instinct Founder
Patrick O'ShaughnessyNoah Shinn
Invite-only Instinct is nearing $1 billion in annual transaction volume, growing 10–11% day over day with $0 spent on marketing.Shinn envisions Apple Pay-style merchant-funded distribution; 40% share a personal credit card within three weeks, and trusted users show about 80% retention.With compute procurement taking months, 5–8% daily compounding could imply 100 million users, while mis-sizing capacity can cost 3–4×.
Gabe Stengel - Building Investing Superintelligence - [Invest Like the Best, EP.492]
Patrick O'ShaughnessyGabe Stengel
Rogo’s model-era progression—from o1 Pro’s reliable search to Opus 4.5 handling junior finance work—supports a two-year race to redesign investment firms, not wait for better models.Its wedge is private-market dealmaking, where data rooms, DDQs, CRM and LP reporting still lack infrastructure, while high-value ideas can justify extreme token spend.The watchpoints are compaction, standardization, and whether incumbents move aggressively enough.
Walter Russell Mead - How America Keeps Winning - [Invest Like the Best, EP.490]
Patrick O'ShaughnessyWalter Russell Mead
Mead sees a dynamic United States inside a collapsing Pax Americana, with information-revolution productivity keeping American power resilient.The investable question is whether “infostructure” can let AI and remote/hybrid work renew the ownership society while adapting to Ukraine’s drone-driven obsolescence.Taiwan’s “soft blockade” and Japan’s strategic awakening offer geopolitical variables as Trump’s unpredictability continues to erode institutional networks.
Sarah Guo - What the 250 People Building AI Believe - [Invest Like the Best, EP.489]
Patrick O'ShaughnessySarah Guo
Sarah Guo says competitive open-source AI is already widespread, so US restrictions could handicap law-abiding American businesses while adversaries ignore them.Her roughly 250-person network sees recursive self-improvement and “some sort of exponential intelligence” as a one-to-two-year possibility, while Sunday Robotics targets home-robot beta by year-end.Compute independence, regulation, and physical supply chains remain constraints, while Chai Discovery’s $10 million contract and customer adoption test AI’s ability to capture value in biology.
Neil Movva - Making AI 10x Cheaper - [Invest Like the Best, EP.488]
Patrick O'ShaughnessyNeil Movva
Sola Research is repositioning inference around long-running background agents, forecasting workloads shift from 50/50 background and real-time by year-end to 90/10 long term as cheaper tokens unlock unbounded demand.By trading latency for throughput, using overlooked chips and 1MW sites with 95% uptime, Movva targets radically lower costs, while KV-cache waste, idle GPUs, HBM supply, and the durability of frontier labs’ three-to-six-month premium remain key watchpoints.
The AI Selloff Doesn't Match the Data | Top AI Investor Explains
Patrick O'ShaughnessyGavin Baker
Gavin Baker argues that the AI selloff lacks a clear demand break: GPU rental prices, DRAM, tokens, and inference usage are accelerating, while open source shifts margins toward infrastructure rather than eliminating compute demand.Credit and regulation are the real catalysts to monitor, but expiring contracts could reprice installed GPUs sharply higher; Baker also sees SpaceX as an underappreciated compute platform, contingent on power, financing, and political acceptance.









